NARAMIG Tablet Ref.[9706] Active ingredients: Naratriptan

Source: Medicines & Healthcare Products Regulatory Agency (GB)  Revision Year: 2019  Publisher: Glaxo Wellcome UK Ltd, trading as GlaxoSmithKline UK, 980 Great West Road, Brentford, Middlesex, TW8 9GS

Product name and form

Naramig 2.5 mg film-coated tablets.

Pharmaceutical Form

Tablets.

Qualitative and quantitative composition

Tablets containing 2.5 mg of naratriptan as naratriptan hydrochloride.

For the full list of excipients, see section 6.1.

Active Ingredient Description
Naratriptan

Naratriptan has been shown to be a selective agonist for 5 hydroxytryptamine1 (5-HT1) receptors mediating vascular contraction. This receptor is found predominantly in intracranial (cerebral and dural) blood vessels. Naratriptan is indicated for the acute treatment of migraine attacks with or without aura.

List of Excipients

Tablet core:

Microcrystalline cellulose
Anhydrous lactose
Croscarmellose sodium
Magnesium stearate

Film-coat:

Methylhydroxypropylcellulose
Titanium dioxide (E171)
Triacetin
Iron oxide yellow (E172)
Indigo carmine aluminium lake (E132)

Pack sizes and marketing

2, 4, 6 or 12 tablets in a double foil blister pack or child-resistant foil blister pack.

Not all pack sizes may be marketed.

Marketing authorization holder

Glaxo Wellcome UK Ltd, trading as GlaxoSmithKline UK, 980 Great West Road, Brentford, Middlesex, TW8 9GS

Marketing authorization dates and numbers

PL 10949/0273

28 April 2002

Drugs

Drug Countries
NARAMIG Australia, Brazil, Germany, Estonia, Spain, Finland, France, Israel, Lithuania, Netherlands, Poland, Singapore, United Kingdom, South Africa

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.